Learning from nemolizumab: A promising therapy for prurigo nodularis

Brian S. Kim

doi:10.1016/j.jaci.2024.02.016

Learning from nemolizumab: A promising therapy for prurigo nodularis

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	1548-1549
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology
Volume	153
Issue number	6
DOIs	https://doi.org/10.1016/j.jaci.2024.02.016
State	Published - Jun 2024

Keywords

Atopic dermatitis
IL-31
IL-4Rα
dupilumab
nemolizumab
oncostatin M
prurigo nodularis

Access to Document

10.1016/j.jaci.2024.02.016

Cite this

@article{1b29c9432bab4cb08525cb4eea85c026,

title = "Learning from nemolizumab: A promising therapy for prurigo nodularis",

keywords = "Atopic dermatitis, IL-31, IL-4Rα, dupilumab, nemolizumab, oncostatin M, prurigo nodularis",

author = "Kim, {Brian S.}",

year = "2024",

month = jun,

doi = "10.1016/j.jaci.2024.02.016",

language = "English",

volume = "153",

pages = "1548--1549",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "6",

}

TY - JOUR

T1 - Learning from nemolizumab

T2 - A promising therapy for prurigo nodularis

AU - Kim, Brian S.

PY - 2024/6

Y1 - 2024/6

KW - Atopic dermatitis

KW - IL-31

KW - IL-4Rα

KW - dupilumab

KW - nemolizumab

KW - oncostatin M

KW - prurigo nodularis

UR - http://www.scopus.com/inward/record.url?scp=85189700203&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2024.02.016

DO - 10.1016/j.jaci.2024.02.016

M3 - Editorial

C2 - 38460679

AN - SCOPUS:85189700203

SN - 0091-6749

VL - 153

SP - 1548

EP - 1549

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 6

ER -